EUDA Health Holdings Warrant
EUDAW
6 hedge funds and large institutions have $16.7K invested in EUDA Health Holdings Warrant in 2026 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
1.86% less ownership
Funds ownership: 8.89% → 7.03% (-1.9%)
14% less funds holding
Funds holding: 7 → 6 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
87% less capital inflows, than outflows
Capital inflows: $911 | Capital outflows: $6.94K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$908 |
| 2 |
Tower Research Capital (TRC)
New York
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$6.94K |
| 2 |
Clear Street
New York
|
-$2 |
EUDAW Hedge Fund Activity: Q3 2026 in Review
6 of the 8,184 institutional investors tracked by Wall St. Rank reported a position in EUDA Health Holdings Warrant (EUDAW) for Q3 2026, worth a combined $16.7K — down 21% from $21.2K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of EUDAW and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Susquehanna International Group, adding an estimated $908. The largest seller was D.E. Shaw & Co, exiting entirely with an estimated $6.94K sold.
- 6 institutional investors held EUDA Health Holdings Warrant (EUDAW) as of Q3 2026, down from 7 in Q2 2026.
- Funds reported $16.7K of EUDA Health Holdings Warrant stock for Q3 2026, down 21% quarter-over-quarter.
- 1 fund opened new EUDA Health Holdings Warrant positions in Q3 2026 and 2 closed out, a net change of -1 holder.
- The largest EUDA Health Holdings Warrant buyer in Q3 2026 was Susquehanna International Group, an estimated $908 added.
- The largest EUDA Health Holdings Warrant seller in Q3 2026 was D.E. Shaw & Co, an estimated $6.94K sold.
Based on aggregated 13F filings for Q3 2026.